Purchase Order 36C24823P2639

Award Date 9/22/23
Potential Completion Date 10/22/23
Potential Value $32K
Ultimate Awardee
Mckesson Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Irving, TX 75039, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded McKesson Corporation a purchase order valued at approximately $5,200 for the delivery of alvimopan capsules. As the prime contractor, McKesson will provide 12 mg capsules of the prescription drug to support VA-VHA programs. Performance will take place at McKesson's distribution facility in Irving, Texas, with deliveries required between November 1-14, 2023. The firm fixed price...
McKesson Corporation, doing business as McKesson Drug Company, has been awarded a $56,559.48 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to deliver emergency supplies of alvimopan 12mg capsules. The place of performance is Irving, Texas, with delivery required by February 29, 2024. McKesson will serve as the prime contractor, with no subcontractors or set aside designation involved. This supports the...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 awarded McKesson Corporation, doing business as McKesson Drug Company, a $10,392.80 firm fixed price purchase order to supply alvimopan capsules. As the parent company of McKesson Drug Company, McKesson Corporation will perform under the contract. The place of performance is McKesson's Charleston, South Carolina distribution center. The contract period of performance spans from October 27,...
McKesson Corporation has been awarded a $14,139.87 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to deliver alvimopan tablets in boxes of 12. The place of performance is Irving, Texas, with an expected completion date of February 7, 2024. No set aside designation was applied to this procurement. McKesson will serve as the prime contractor in fulfilling this requirement for pharmaceutical products to...
McKesson Corporation, doing business as McKesson, has been awarded a purchase order contract valued at approximately $14,140 by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA VHA VISN 8) to provide alvimopan. The firm fixed price contract runs from October 24, 2023 through October 30, 2023 and will be performed in Irving, Texas. No additional details were provided regarding the original solicitation or whether this contract is...
McKesson Corporation, doing business as McKesson, has been awarded a $31,178.40 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 (VA VHA VISN 12) to deliver alvimopan. The single award contract has a period of performance from June 28, 2023 through July 31, 2023 and will be performed in Irving, Texas. McKesson will serve as the prime contractor to fulfill this requirement to supply the specified...
McKesson Corporation, doing business as McKesson, has been awarded a $28,279.74 firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 (VA VHA VISN 21) to deliver alvimopan drug from July 18, 2023 through September 30, 2023. The place of performance will be McKesson's facility located in Irving, Texas. No additional details were provided regarding the original solicitation or whether this contract is...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order contract to Mckesson Corporation, a healthcare services and information technology company, for the delivery of the pharmaceutical product Alvimopan. The contract has a potential value of $10,392.80 and a completion date of July 31, 2024. This award is not associated with a set-aside program. Mckesson has previously provided a range of pharmaceutical products and services to various...
The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order contract to Mckesson Corporation, a healthcare services and information technology company, to provide the pharmaceutical product ALVIMOPAN. The contract has a potential value of $41,571.20 and a completion date of December 12, 2023. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Mckesson has previously provided various...
McKesson Corporation has been awarded a firm fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 for $10,312.20. The contract has no set-aside designation and calls for McKesson to provide unspecified products to support healthcare services for veterans in Irving, Texas. McKesson will deliver the products under this contract by March 21, 2024. McKesson serves as a prime vendor for the Department of Veterans...

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded McKesson Corporation, doing business as McKesson Drug Company, a $31,864.84 firm fixed price purchase order contract to supply alvimopan 12mg capsules. As the prime contractor, McKesson will deliver the requested pharmaceutical products to a location in Irving, Texas by the end date of October 22, 2023. The contract was awarded utilizing McKesson's position on the Federal Supply Schedule, which allows VA facilities to efficiently procure medical and surgical supplies from pre-competed contracts. No subcontractors or set-aside designations were identified. This purchase will support the VA's mission to provide quality healthcare to America's veterans.

Generated 12/16/23, 4:16 AM